Zendia GmbH is aiming to enter the market bolstered by a substantial grant of 290,000 Euros from the German Federal Ministry of Education and Research (BMBF). The grant, awarded under the “Transfer Medical Solution in Patient Care – Prove Clinical Evidence without Delay” program, will support Zendia’s innovative proposal titled “Clinical Evidence: Diagnostic Detection of Malaria Pathogens in Patient’s Blood at the Point-of-Care (InfectoTest®)”. This pivotal funding paves the way for Zendia to deliver timely and accurate malaria diagnostics, transforming patient care with InfectoTest®!
Zendia Targets Market Entry with Innovative Malaria Diagnostic Solution
